Hazlett, Burt & Watson’s GE HealthCare GEHC Stock Holding History

Hazlett, Burt & Watson’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2K	Sell	32 -50	-61%	-$3.38K	﹤0.01%	850
2026 Q2	$5K	Sell	82 -60	-42%	-$3.94K	﹤0.01%	771
2026 Q1	$11K	Hold	142	–	–	﹤0.01%	677
2025 Q4	$12K	Sell	142 -40	-22%	-$3.12K	﹤0.01%	677
2025 Q3	$15K	Buy	182 +86	+90%	+$6.41K	0.01%	609
2025 Q2	$7K	Sell	96 -238	-71%	-$16.6K	﹤0.01%	635
2025 Q1	$27K	Sell	334 -387	-54%	-$33.3K	0.01%	453
2024 Q4	$57K	Hold	721	–	–	0.03%	345
2024 Q3	$67K	Buy	721 +639	+779%	+$53.6K	0.03%	318
2024 Q2	$7K	Sell	82 -23	-22%	-$1.88K	﹤0.01%	551
2024 Q1	$9K	Sell	105 -15	-13%	-$1.25K	0.01%	522
2023 Q4	$10K	Sell	120 -333	-74%	-$23.3K	0.01%	496
2023 Q3	$31K	Buy	453 +1	+0.2%	+$73	0.02%	361
2023 Q2	$37K	Sell	452 -19	-4%	-$1.52K	0.03%	342
2023 Q1	$39K	Buy	+471	New	+$33.6K	0.03%	310

Other funds holding GEHC

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Locust Wood Capital Advisers New York $4.43B AUM 19.95% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Hazlett, Burt & Watson's GEHC Position: Q3 2026 in Review

Hazlett, Burt & Watson reduced its GE HealthCare (GEHC) stake by 61% in Q3 2026, selling an estimated $3.38K and leaving 32 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #850.

Hazlett, Burt & Watson first reported a position in GEHC in Q1 2023 and has held it in 15 quarters since. The position peaked at $67K in Q3 2024. 657 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

Hazlett, Burt & Watson held 32 shares of GE HealthCare worth $2K as of Q3 2026.
Hazlett, Burt & Watson sold 50 GE HealthCare shares in Q3 2026, an estimated $3.38K.
GE HealthCare made up ﹤0.01% of Hazlett, Burt & Watson's portfolio in Q3 2026, its #850 holding.
Hazlett, Burt & Watson first reported a position in GE HealthCare in Q1 2023 and has held it in 15 quarters since.
Hazlett, Burt & Watson's GE HealthCare position peaked at $67K in Q3 2024.
657 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q3 2026, filed 4 Nov 2026.